CreditReports.dk
HomeScreen companies

AMPLEXA GENETICS A/S Financials, key figures and credit report

CVR number: 29428441 Established 2006 Industry: 71 Architectural and engineering activities; technical testing and analysis
Company contact details
Sverigesgade 24, 5000 Odense C info@amplexa.com tel: 66116628
Gross profit 4 009.0 kDKK FY 2025 +18% vs 2024
EBIT -1 729.8 kDKK FY 2025 +78.3% vs 2024
Net debt 11 219.8 kDKK FY 2025 +10.6% vs 2024
Quick ratio 1.2 FY 2025 +0.1 vs 2024

Income statement (kDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales
Gross profit20 278.075 494.693 224.943 398.664 009.03
Employee benefit expenses-9 030.71-7 227.94-6 638.95-6 404.63-5 368.29
Other operating expenses-4 476.76
Total depreciation- 809.99- 817.74- 649.09- 480.46- 370.58
EBIT10 437.36-2 550.99-4 063.10-7 963.19-1 729.83
Other financial income48.473.02
Other financial expenses- 494.72- 473.59-31.82-33.66- 134.48
Pre-tax profit9 942.64-3 024.59-4 046.44-7 993.82-1 864.31
Income taxes2 385.71742.46915.37-3 114.52281.07
Net earnings12 328.35-2 282.13-3 131.08-11 108.34-1 583.23

Assets (kDKK)

2021
2022
2023
2024
2025
Development expenditure1 782.762 975.764 476.76
Intangible assets total1 782.762 975.764 476.76
Machinery and equipment2 405.841 588.10939.01458.56124.15
Tangible assets total2 405.841 588.10939.01458.56124.15
Holdings in group member companies18.7918.79
Investments total189.79196.52141.78125.97128.98
Long term receivables total
Finished products/goods1 305.141 688.951 436.611 020.31917.44
Inventories total1 305.141 688.951 436.611 020.31917.44
Current trade debtors2 161.98820.66385.26570.10201.15
Current amounts owed by group member comp.279.98296.68
Current owed by particip. interest comp.329.85343.15
Prepayments and accrued income123.3854.56292.24230.32
Current other receivables17.49385.1850.0076.00
Current deferred tax assets2 385.713 128.173 781.07336.34281.07
Short term receivables total4 968.544 300.064 551.521 578.521 131.69
Cash and bank deposits7 729.361 534.553 429.89463.74590.25
Cash and cash equivalents7 729.361 534.553 429.89463.74590.25
Balance sheet total (assets)18 381.4512 283.9514 975.573 647.092 892.50

Equity and liabilities (kDKK)

2021
2022
2023
2024
2025
Share capital600.00600.0020 600.0020 600.0020 600.00
Other reserves1 390.552 321.093 491.87
Retained earnings-26 527.39-15 129.58-18 582.49-18 221.69-29 330.03
Profit of the financial year12 328.35-2 282.13-3 131.08-11 108.34-1 583.23
Shareholders equity total-12 208.48-14 490.612 378.31-8 730.03-10 313.27
Capital loans26 260.0025 610.0010 610.0010 610.0010 610.00
Non-current owed to participating1 200.00
Non-current liabilities total26 260.0025 610.0010 610.0010 610.0011 810.00
Short-term capital loans1 600.00
Advances received6.019.209.21
Current trade creditors1 118.33560.82405.52675.56506.03
Other non-interest bearing current liabilities1 605.59594.551 581.751 082.35889.73
Current liabilities total4 329.931 164.571 987.271 767.131 395.76
Balance sheet total (liabilities)18 381.4512 283.9514 975.573 647.092 892.50
Page generated